Tech Company Financing Transactions
MolecularMD Funding Round
Ballast Point Ventures participated in a $3 million capital raise for MolecularMD. This venture round closed on 1/30/2009.
Transaction Overview
Company Name
Announced On
1/30/2009
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Undisclosed
Investors
Ballast Point Ventures (Dick Brandewie)
Proceeds Purpose
This financing will be used to build MolecularMD's corporate infrastructure and to expand the company's assay portfolio.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1341 SW. Custer Dr.
Portland, OR 97219
USA
Portland, OR 97219
USA
Phone
Website
Email Address
Overview
Founded in 2006, MolecularMD is a molecular diagnostics company specializing in clinical development and commercialization of state-of-the-art genomic assays to measure patient response and resistance to targeted cancer therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Snyder
Chief Financial Officer
Ryan Dunlap
Chief Marketing Officer
Fritz Eibel
Chief Medical Officer
Chad Galderisi
VP - Regulatory Affairs
Cindy Spittle
Browse more venture capital transactions:
Prev: 1/30/2009: Social Media Networks venture capital transaction
Next: 1/30/2009: Diagnosoft venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs